Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2051865rdf:typepubmed:Citationlld:pubmed
pubmed-article:2051865lifeskim:mentionsumls-concept:C0021670lld:lifeskim
pubmed-article:2051865lifeskim:mentionsumls-concept:C0012702lld:lifeskim
pubmed-article:2051865lifeskim:mentionsumls-concept:C0023175lld:lifeskim
pubmed-article:2051865lifeskim:mentionsumls-concept:C0011900lld:lifeskim
pubmed-article:2051865lifeskim:mentionsumls-concept:C1512806lld:lifeskim
pubmed-article:2051865pubmed:issue20lld:pubmed
pubmed-article:2051865pubmed:dateCreated1991-7-25lld:pubmed
pubmed-article:2051865pubmed:abstractTextA single dose of 250 mg disopyramide provoked severe hypoglycaemia and confusion in a 75-year-old woman. During subsequent investigation, fasting provoked symptomatic hypoglycaemia (venous blood glucose, 1.6 mumol/1) after 23 hours, plasma concentrations of insulin and C peptide then being 19 micrograms/ml and 0.85 pmol/l, respectively; computerised tomography and ultrasonography of the pancreas n.a.d. However, at laparotomy, a 10 mm diameter insulinoma was detected by intra-operative ultrasonography and palpation. The tumour was removed. To our knowledge, this is the first reported case of an insulinoma being detected due to intake of disopyramide.lld:pubmed
pubmed-article:2051865pubmed:languageswelld:pubmed
pubmed-article:2051865pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2051865pubmed:citationSubsetIMlld:pubmed
pubmed-article:2051865pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2051865pubmed:statusMEDLINElld:pubmed
pubmed-article:2051865pubmed:monthMaylld:pubmed
pubmed-article:2051865pubmed:issn0023-7205lld:pubmed
pubmed-article:2051865pubmed:authorpubmed-author:GrimeliusLLlld:pubmed
pubmed-article:2051865pubmed:authorpubmed-author:GrillVVlld:pubmed
pubmed-article:2051865pubmed:authorpubmed-author:HambergerBBlld:pubmed
pubmed-article:2051865pubmed:authorpubmed-author:AlvarssonMMlld:pubmed
pubmed-article:2051865pubmed:issnTypePrintlld:pubmed
pubmed-article:2051865pubmed:day15lld:pubmed
pubmed-article:2051865pubmed:volume88lld:pubmed
pubmed-article:2051865pubmed:ownerNLMlld:pubmed
pubmed-article:2051865pubmed:authorsCompleteYlld:pubmed
pubmed-article:2051865pubmed:pagination1896lld:pubmed
pubmed-article:2051865pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2051865pubmed:meshHeadingpubmed-meshheading:2051865-...lld:pubmed
pubmed-article:2051865pubmed:meshHeadingpubmed-meshheading:2051865-...lld:pubmed
pubmed-article:2051865pubmed:meshHeadingpubmed-meshheading:2051865-...lld:pubmed
pubmed-article:2051865pubmed:meshHeadingpubmed-meshheading:2051865-...lld:pubmed
pubmed-article:2051865pubmed:meshHeadingpubmed-meshheading:2051865-...lld:pubmed
pubmed-article:2051865pubmed:meshHeadingpubmed-meshheading:2051865-...lld:pubmed
pubmed-article:2051865pubmed:meshHeadingpubmed-meshheading:2051865-...lld:pubmed
pubmed-article:2051865pubmed:year1991lld:pubmed
pubmed-article:2051865pubmed:articleTitle[Intake of disopyramide led to diagnosis of insulinoma].lld:pubmed
pubmed-article:2051865pubmed:affiliationendokrinologiska kliniken, Akademiska sjukhuset, Uppsala.lld:pubmed
pubmed-article:2051865pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2051865pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:2051865pubmed:publicationTypeCase Reportslld:pubmed